BioCentury
ARTICLE | Clinical News

PXT002331: Phase I data

October 3, 2016 7:00 AM UTC

A double-blind, placebo-controlled, U.K. Phase I trial in 64 healthy volunteers showed that single and multiple ascending doses of oral PXT002331 were well tolerated. In 2013, Prexton exercised an opt...